Found: 9
Select item for more details and to access through your institution.
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 831, doi. 10.1177/1078155218764285
- By:
- Publication type:
- Article
Selective Treatment of Hypoxic Tumor Cells In Vivo: Phosphate Pre-Prodrugs of Nitro Analogues of the Duocarmycins.
- Published in:
- Angewandte Chemie, 2011, v. 123, n. 11, p. 2654, doi. 10.1002/ange.201004456
- By:
- Publication type:
- Article
Erratum to: Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 543, doi. 10.1007/s00280-010-1354-5
- By:
- Publication type:
- Article
Transport and Bioavailability Studies of Astragaloside IV, an Active Ingredient inRadix Astragali.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2004, v. 95, n. 6, p. 295, doi. 10.1111/j.1742-7843.2004.t01-1-pto950508.x
- By:
- Publication type:
- Article
Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00531
- By:
- Publication type:
- Article
Initial testing of the hypoxia-activated prodrug PR-104 by the pediatric preclinical testing program.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 57, n. 3, p. 443, doi. 10.1002/pbc.22921
- By:
- Publication type:
- Article
Selective Treatment of Hypoxic Tumor Cells In Vivo: Phosphate Pre-Prodrugs of Nitro Analogues of the Duocarmycins.
- Published in:
- Angewandte Chemie International Edition, 2011, v. 50, n. 11, p. 2606, doi. 10.1002/anie.201004456
- By:
- Publication type:
- Article
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 496, doi. 10.1186/1471-2407-12-496
- By:
- Publication type:
- Article